Inactive Instrument

Press Releases Theseus Pharmaceuticals, Inc.

Equities

THRX

US88369M1018

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Theseus Pharmaceuticals Announces Closing of Tender Offer	Feb. 14	PR
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals	Jan. 30	BU
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN	Jan. 11	PR
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX	Dec. 31	BU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN	Dec. 27	PR
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders	Dec. 22	BU
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right	Dec. 22	PR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX	Dec. 22	PR
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra	Dec. 22	PR
Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC	Nov. 27	PR
Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives	Nov. 13	PR
Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conference	Nov. 07	PR
Theseus Pharmaceuticals Announces Business Highlights and Reports Second Quarter 2023 Financial Results	23-08-10	PR
Thinking about buying stock in Knightscope, Mullen Automotive, Nikola, Ideanomics, or Theseus Pharmaceuticals?	23-07-14	PR
Theseus Pharmaceuticals to Discontinue Enrollment in Phase 1/2 Study and Terminate Development of THE-630 in Patients with GIST	23-07-13	PR
THESEUS PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-09	AQ
Theseus Pharmaceuticals to Participate in the Jefferies Healthcare Conference	23-05-31	PR
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST	23-05-25	PR
Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2023 Financial Results	23-05-12	AQ
THESEUS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Theseus Pharmaceuticals, Inc.

Equities

THRX

US88369M1018

Press Releases

Filters